TY - STD TI - Anderson ME. Update on survival in osteosarcoma. Orthop Clin North Am 2016;47(1):283–292. doi: https://doi.org/10.1016/j.ocl.2015.08.022. PubMed PMID: 26614941. ID - ref1 ER - TY - STD TI - Marko TA, Diessner BJ, Spector LG. Prevalence of Metastasis at Diagnosis of Osteosarcoma: An International Comparison. Pediatr Blood Cancer. 2016;63(6):1006–1011. doi: https://doi.org/10.1002/pbc.25963. PubMed PMID: 26929018; PMCID: PMC4833631. ID - ref2 ER - TY - JOUR AU - Mueller, F. AU - Fuchs, B. AU - Kaser-Hotz, B. PY - 2007 DA - 2007// TI - Comparative biology of human and canine osteosarcoma JO - Anticancer Res VL - 27 ID - Mueller2007 ER - TY - STD TI - Barroga E, Kadosawa T, Okumura M. Establishment and characterization of the growth and pulmonary metastasis of a highly lung metastasizing cell line from canine osteosarcoma in nude mice. J Vet Med Sci 1999;61:361–7. PubMed PMID: doi:https://doi.org/10.1292/jvms.61.361. ID - ref4 ER - TY - JOUR AU - Collet, C. AU - Schiltz, C. AU - Geoffroy, V. PY - 2008 DA - 2008// TI - The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation JO - FASEB J VL - 22 UR - https://doi.org/10.1096/fj.07-9209com DO - 10.1096/fj.07-9209com ID - Collet2008 ER - TY - STD TI - Klein-Nulend J, Westbroek I, van der Plas A. Expression of serotonin receptors in bone. J Bone Miner Res 2001;16:S176 - S. ID - ref6 ER - TY - STD TI - Westbroek I, van der Plas A, de Rooij K. Expression of serotonin receptors in bone. J Biol Chem 2001;276:28961–8. PubMed PMID: doi:https://doi.org/10.1074/jbc.M101824200. ID - ref7 ER - TY - STD TI - Bracha S, Viall A, Goodall C, Stang B, Ruaux C, Seguin B, Chappell PE. The expression and role of serotonin receptor 5HTR2A in canine osteoblasts and an osteosarcoma cell line. BMC Vet Res. 2013;9:251. doi: https://doi.org/10.1186/1746-6148-9-251. PubMed PMID: 24330646; PMCID: PMC3895671. ID - ref8 ER - TY - STD TI - Hu CD, Choo R, Huang J. Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure. Front Oncol. 2015;5(90). https://doi.org/10.3389/fonc.2015.00090. PubMed PMID: 25927031 PMC4396194. ID - ref9 ER - TY - STD TI - Quiros-Gonzalez I, Sainz RM, Hevia D, Mayo JC. MnSOD drives neuroendocrine differentiation, androgen independence, and cell survival in prostate cancer cells. Free Radic Biol Med 2011;50(4):525–536. doi: https://doi.org/10.1016/j.freeradbiomed.2010.10.715. PubMed PMID: 21056653. ID - ref10 ER - TY - STD TI - Walker GE, Antoniono RJ, Ross HJ, Paisley TE, Oh Y. Neuroendocrine-like differentiation of non-small cell lung carcinoma cells: regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1. Oncogene 2006;25(13):1943–1954. doi: https://doi.org/10.1038/sj.onc.1209213. PubMed PMID: 16302002. ID - ref11 ER - TY - STD TI - von Alten J, Fister S, Schulz H, Viereck V, Frosch KH, Emons G, Grundker C. GnRH analogs reduce invasiveness of human breast cancer cells. Breast Cancer Res Treat 2006;100(1):13–21. Epub 2006/06/08. doi: https://doi.org/10.1007/s10549-006-9222-z. PubMed PMID: 16758121. ID - ref12 ER - TY - STD TI - Harrison GS, Wierman ME, Nett TM, Glode LM. Gonadotropin-releasing hormone and its receptor in normal and malignant cells. Endocr Relat Cancer 2004;11(4):725–748. doi: https://doi.org/10.1677/erc.1.00777. PubMed PMID: 15613448. ID - ref13 ER - TY - STD TI - Kakar SS, Jennes L. Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues. Cancer Lett 1995;98(1):57–62. PubMed PMID: 8529206. ID - ref14 ER - TY - STD TI - Bhattacharya M, Babwah AV. Kisspeptin: beyond the brain. Endocrinology 2015;156(4):1218–1227. Epub 2015/01/16. doi: https://doi.org/10.1210/en.2014-1915. PubMed PMID: 25590245. ID - ref15 ER - TY - STD TI - Wang FS, Chen H, Wu ZY, Lin JH. KISS1 expression in osteosarcoma: high in chinese clinical cases, but lower in cell lines. Asian Pac J Cancer Prev 2011;12(12):3229–3234. Epub 2011/01/01. PubMed PMID: 22471458. ID - ref16 ER - TY - STD TI - Zhang Y, Tang YJ, Li ZH, Pan F, Huang K, Xu GH. KiSS1 inhibits growth and invasion of osteosarcoma cells through inhibition of the MAPK pathway. Eur J Histochem. 2013;57(4):e30. Epub 2014/01/21. doi: https://doi.org/10.4081/ejh.2013.e30ejh.2013.e30 [pii]. PubMed PMID: 24441183; PMCID: 3896032. ID - ref17 ER - TY - JOUR AU - Horwood, N. J. AU - Elliott, J. AU - Martin, T. J. AU - Gillespie, M. T. PY - 1998 DA - 1998// TI - Osteotropic agents regulate the expression of osteoclast differentiation factor and Osteoprotegerin in osteoblastic stromal cells JO - Endocrinology VL - 139 UR - https://doi.org/10.1210/endo.139.11.6433 DO - 10.1210/endo.139.11.6433 ID - Horwood1998 ER - TY - JOUR AU - Dougall, W. C. AU - Chaisson, M. PY - 2006 DA - 2006// TI - The RANK/RANKL/OPG triad in cancer-induced bone diseases JO - Cancer Metastasis Rev VL - 25 UR - https://doi.org/10.1007/s10555-006-9021-3 DO - 10.1007/s10555-006-9021-3 ID - Dougall2006 ER - TY - JOUR AU - Bord, S. AU - Ireland, D. C. AU - Beavan, S. R. AU - Compston, J. E. PY - 2003 DA - 2003// TI - The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts JO - Bone VL - 32 UR - https://doi.org/10.1016/S8756-3282(02)00953-5 DO - 10.1016/S8756-3282(02)00953-5 ID - Bord2003 ER - TY - JOUR AU - Good, C. R. AU - O'Keefe, R. J. AU - Puzas, J. E. AU - Schwarz, E. M. AU - Rosier, R. N. PY - 2002 DA - 2002// TI - Immunohistochemical study of receptor activator of nuclear factor kappa-B ligand (RANK-L) in human osteolytic bone tumors JO - J Surg Oncol VL - 79 UR - https://doi.org/10.1002/jso.10067 DO - 10.1002/jso.10067 ID - Good2002 ER - TY - JOUR AU - Dolcet, X. AU - Llobet, D. AU - Pallares, J. AU - Matias-Guiu, X. PY - 2005 DA - 2005// TI - NF-kB in development and progression of human cancer JO - Virchows Arch VL - 446 UR - https://doi.org/10.1007/s00428-005-1264-9 DO - 10.1007/s00428-005-1264-9 ID - Dolcet2005 ER - TY - JOUR AU - Schubert, A. AU - Schulz, H. AU - Emons, G. AU - Gründker, C. PY - 2008 DA - 2008// TI - Expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression JO - Gynecol Endocrinol VL - 24 UR - https://doi.org/10.1080/09513590802095845 DO - 10.1080/09513590802095845 ID - Schubert2008 ER - TY - STD TI - Zhang G, Li J, Purkayastha S, Tang Y, Zhang H, Yin Y, Li B, Liu G, Cai D. Hypothalamic programming of systemic ageing involving IKK-β NF-κB and GnRH, Nature 2013;497:211. doi: https://doi.org/10.1038/nature12143, https://www.nature.com/articles/nature12143#supplementary-information. UR - https://www.nature.com/articles/nature12143#supplementary-information ID - ref24 ER - TY - STD TI - Golden D, Saria EA, Hansen MF. Regulation of osteoblast migration involving receptor activator of nuclear factor-kappa B (RANK) signaling. J Cell Physiol 2015;230(12):2951–2960. doi: https://doi.org/10.1002/jcp.25024. PubMed PMID: 25893522. ID - ref25 ER - TY - STD TI - Albers-Wolthers KH, de Gier J, Kooistra HS, Rutten VP, van Kooten PJ, de Graaf JJ, Leegwater PA, Millar RP, Schaefers-Okkens AC. Identification of a novel kisspeptin with high gonadotrophin stimulatory activity in the dog. Neuroendocrinology 2014;99(3–4):178–189. Epub 2014/06/07. doi: https://doi.org/10.1159/000364877000364877 [pii]. PubMed PMID: 24902774. ID - ref26 ER - TY - STD TI - Chappell PE, White RS, Mellon PL. Circadian gene expression regulates pulsatile gonadotropin-releasing hormone (GnRH) secretory patterns in the hypothalamic GnRH-secreting GT1–7 cell line. J Neurosci. 2003;23(35):11202–11213. Epub 2003/12/06. doi: 23/35/11202 [pii]. PubMed PMID: 14657179; PMCID: 2932475. ID - ref27 ER - TY - STD TI - Krsmanovic LZ, Martinez-Fuentes AJ, Arora KK, Mores N, Navarro CE, Chen HC, Stojilkovic SS, Catt KJ. Autocrine regulation of gonadotropin-releasing hormone secretion in cultured hypothalamic neurons. Endocrinology 1999;140(3):1423–1431. Epub 1999/03/06. PubMed PMID: 10067871. ID - ref28 ER - TY - STD TI - Chen SQ, Chen ZH, Lin SY, Dai QB, Fu LX, Chen RQ. KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients. World J Gastroenterol. 2014;20(29):10071–10081. doi: https://doi.org/10.3748/wjg.v20.i29.10071. PubMed PMID: 25110434; PMCID: PMC4123336. ID - ref29 ER - TY - STD TI - Jarzabek K, Koda M, Kozlowski L, Milewski R, Wolczynski S. Immunohistochemical study of KiSS1 and KiSS1R expression in human primary breast cancer: Association with breast cancer receptor status, proliferation markers and clinicopathological features. Histol Histopathol. 2015;30(6):715–723. doi: https://doi.org/10.14670/HH-30.715. PubMed PMID: 25535062. ID - ref30 ER - TY - STD TI - Kostakis ID, Agrogiannis G, Vaiopoulos AG, Mylona E, Patsouris E, Kouraklis G, Koutsilieris M. A clinicopathological analysis of KISS1 and KISS1R expression in colorectal cancer. APMIS 2015;123(7):629–637. doi: https://doi.org/10.1111/apm.12397. PubMed PMID: 26010933. ID - ref31 ER - TY - JOUR AU - Teplyuk, N. M. AU - Galindo, M. AU - Teplyuk, V. I. AU - Pratap, J. AU - Young, D. W. AU - Lapointe, D. AU - Javed, A. AU - Stein, J. L. AU - Lian, J. B. AU - Stein, G. S. AU - Wijnen, A. J. PY - 2008 DA - 2008// TI - Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors JO - J Biol Chem VL - 283 UR - https://doi.org/10.1074/jbc.M802453200 DO - 10.1074/jbc.M802453200 ID - Teplyuk2008 ER - TY - JOUR AU - Dotterweich, J. AU - Tower, R. J. AU - Brandl, A. AU - Müller, M. AU - Hofbauer, L. C. AU - Beilhack, A. AU - Ebert, R. AU - Glüer, C. C. AU - Tiwari, S. AU - Schütze, N. AU - Jakob, F. PY - 2016 DA - 2016// TI - The KISS1 receptor as an in vivo microenvironment imaging biomarker of multiple myeloma bone disease JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0155087 DO - 10.1371/journal.pone.0155087 ID - Dotterweich2016 ER - TY - STD TI - Schmidt E, Haase M, Ziegler E, Emons G, Grundker C. Kisspeptin-10 inhibits stromal-derived factor 1-induced invasion of human endometrial cancer cells. Int J Gynecol Cancer 2014;24(2):210–217. doi: https://doi.org/10.1097/IGC.0000000000000050. PubMed PMID: 24407584. ID - ref34 ER - TY - STD TI - Tan K, Cho SG, Luo W, Yi T, Wu X, Siwko S, Liu M, Yuan W. KiSS1-induced GPR54 signaling inhibits breast cancer cell migration and epithelial-mesenchymal transition via protein kinase D1. Curr Mol Med 2014;14(5):652–662. PubMed PMID: 24894166. ID - ref35 ER - TY - STD TI - Usui S, Iso Y, Sasai M, Mizukami T, Mori H, Watanabe T, Shioda S, Suzuki H. Kisspeptin-10 induces endothelial cellular senescence and impaired endothelial cell growth. Clin Sci (Lond) 2014;127(1):47–55. doi: https://doi.org/10.1042/CS20130505. PubMed PMID: 24405415. ID - ref36 ER - TY - STD TI - Cho SG, Wang Y, Rodriguez M, Tan K, Zhang W, Luo J, Li D, Liu M. Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis. Cancer Res. 2011;71(20):6535–6546. doi: https://doi.org/10.1158/0008-5472.CAN-11-0329. PubMed PMID: 21852382; PMCID: PMC4949591. ID - ref37 ER - TY - STD TI - Cvetkovic D, Dragan M, Leith SJ, Mir ZM, Leong HS, Pampillo M, Lewis JD, Babwah AV, Bhattacharya M. KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells. Endocrinology 2013;154(6):1999–2014. Epub 2013/03/26. doi: https://doi.org/10.1210/en.2012-2164en.2012-2164 [pii]. PubMed PMID: 23525242. ID - ref38 ER - TY - STD TI - Zajac M, Law J, Cvetkovic DD, Pampillo M, McColl L, Pape C, Di Guglielmo GM, Postovit LM, Babwah AV, Bhattacharya M. GPR54 (KISS1R) transactivates EGFR to promote breast cancer cell invasiveness. PLoS One. 2011;6(6):e21599. doi: https://doi.org/10.1371/journal.pone.0021599. PubMed PMID: 21738726; PMCID: PMC3125256. ID - ref39 ER - TY - STD TI - Schubert A, Schulz H, Emons G, Grundker C. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression. Gynecol Endocrinol 2008;24(6):331–338. doi: https://doi.org/10.1080/09513590802095845. PubMed PMID: 18584413. ID - ref40 ER - TY - STD TI - Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100(1):57–70. PubMed PMID: 10647931. ID - ref41 ER - TY - STD TI - Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144(5):646–674. doi: https://doi.org/10.1016/j.cell.2011.02.013. PubMed PMID: 21376230. ID - ref42 ER -